UNSPSC 51241511: Dextran 70/hypromellose

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP500. This VA Drug Class (OP500) classifies this compound as belonging to the group EYE WASHES/LUBRICANTS.

UNSPSC 51241511 Dextran 70/hypromellose is a Commodity code covering ophthalmic and pharmaceutical preparations that state and local governments procure for health facilities, clinics, and institutional care settings. The code encompasses branded and generic pharmaceutical products distributed through established wholesaler networks and cooperative purchasing vehicles, with recent activity focusing on multi-source generic pharmaceuticals and over-the-counter products supplied to state agencies and participating local jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The solicitation requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded contracts effective July 1, 2026 and extending for two years. Vendors must demonstrate cGMP and Drug Supply Chain Security Act (DSCSA) compliance, maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems, and submit detailed product information including NDC codes, SKUs, and UPCs in Excel/CSV format. Evaluation emphasizes price competitiveness (75 percent weight), with secondary consideration of fixed pricing, administrative compliance, EDI capability, and agreement to a 3 percent administrative fee. Proposals are due March 26, 2026, with a questions cutoff on February 18, 2026.